UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
JUNE 8, 2000
------------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------------- ----------- --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
-------------------------------------------------------
(Address of principal executive offices)
336-229-1127
------------
(Registrant's telephone number, including area code)
<PAGE>
ITEM 5. OTHER EVENTS
On June 8, 2000, Laboratory Corporation of America-
Registered Trademark- Holdings (LabCorp-Registered Trademark-
) announced that its Board of Directors has declared a
dividend of $0.08264 per share on the Company's Series A
Preferred Stock, payable in cash. The Board has also
declared a dividend of $0.08264 per share on the Company's
Series B Preferred Stock, payable in shares of Series B
Preferred Stock at the rate of 0.001653 shares per share of
Series B Preferred Stock held. The dividends will be paid on
June 30, 2000 for each issued and outstanding share of
Series A and Series B Preferred Stock to stockholders of
record on June 14, 2000 (whether or not such stockholders
convert their shares after such date), and will cover the
seven days to July 7, 2000, the date set for redemption of
the Series A and Series B Preferred Stock, at an equivalent
annualized rate of $4.25 per share. The dividends will be
paid in addition to the dividends payable on the Series A
and Series B Preferred Stock for the quarterly dividend
period ended June 30, 2000 announced by the Company on May
2, 2000.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) Exhibit
20 Press release of the Company dated
June 8, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
------------------------------
Bradford T. Smith
Executive Vice President,
General Counsel, Secretary
and Compliance Officer
Date: June 12, 2000
<PAGE>
